Skip to content

Clinical trials

Phase 1 Neutropenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neutropenia Phase: Phase 1 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20102
20111
20121
20151
20161
20201
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
National Heart, Lung, and Blood Institute (NHLBI)2
Pfizer2
University of Washington2
Aileron Therapeutics, Inc.1
Children's Oncology Group1
Enzon Pharmaceuticals, Inc.1
Gynecologic Oncology Group1
Mayo Clinic1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neutropenia20
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Burkitt Lymphoma4
Lymphoma, Large B-Cell, Diffuse4
Breast Neoplasms3
Leukemia, Lymphocytic, Chronic, B-Cell3
Leukemia, Myeloid, Acute3
Lymphoma3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.